Delivery Order SPE2DB20D3304-SPE2DB24FW5U7
- Not listed
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Eliquis 5 mg tablets. The $14,273.04 contract has an ultimate completion date of April 10, 2024 and does not have a set-aside designation. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical with a potential value of $999,999,999.00 through December 31, 2025, which...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply Eliquis 5 mg tablets. The contract has a potential value of $5,872.82 and a completion date of March 7, 2024. AmerisourceBergen Drug Corp is the prime contractor on this delivery order, which is not associated with any set-aside program. AmerisourceBergen Drug Corp also holds an indefinite...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply Eliquis 5 mg tablets. The $27,143.18 contract has a period of performance through March 21, 2024. This order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp by DLA, which serves as the primary vehicle for the company to provide pharmaceuticals and...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Eliquis 2.5 mg tablets for a total ceiling value of $1,583.40. The contract has an ultimate completion date of April 1, 2024. AmerisourceBergen Drug Corp is the prime contractor, and the contract does not have a set-aside designation. This delivery order is part of a larger single-award indefinite delivery contract...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Eliquis 5 mg tablets. The $23,922.48 contract has a performance period through March 27, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp is also the prime contractor on a $999,999,999.00 indefinite delivery contract with DLA to provide a comprehensive range of pharmaceutical products...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $7,119.95 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the provision of Eliquis 5 mg tablets and has a performance period through March 13, 2024. AmerisourceBergen Drug Corp is the prime contractor on this order, which was not set aside under any socioeconomic programs. Additionally, AmerisourceBergen Drug Corp holds an Indefinite Delivery...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distributor AmerisourceBergen Corporation. This $9,313.70 contract is for the delivery of 4,563,926,216 units of the medication Eliquis 5 mg tablets. The contract has an ultimate completion date of March 12, 2024 and does not utilize any set-aside designations. AmerisourceBergen Drug Corp holds an indefinite delivery contract with...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) has awarded a delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of Eliquis 5 mg tablets. The contract has a firm fixed price of $14,704.21 and a performance period through April 9, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of up to $999,999,999.00 and a...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of Eliquis 5 mg tablets. The total ceiling value of this contract is $22,619.00 with a period of performance through April 9, 2024. This delivery order falls under a larger $999,999,999.00 indefinite delivery contract (IDC) issued by DLA to AmerisourceBergen Drug Corp as a single award vehicle to supply...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,564,110,749 units of the prescription medication Eliquis 5 mg tablets. The $9,195.48 firm fixed price contract has an ultimate completion date of March 29, 2024. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp as the prime contractor to supply...
- SPE2DB20D3304Indefinite Delivery Contract
- SPE2DB20D3304-SPE2DB24FW5U7Delivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp (a subsidiary of AmerisourceBergen Corporation) to provide Eliquis 5 mg tablets. The $8,770.83 contract has an ultimate completion date of April 10, 2024 and does not have a set-aside designation. AmerisourceBergen Drug Corp provides a wide range of pharmaceutical products and medical supplies to U.S. government agencies, particularly the Department of Defense, through multiple indefinite delivery contracts with DLA. This specific delivery order is part of a larger $999,999,999.00 indefinite delivery contract with DLA that enables AmerisourceBergen to deliver a comprehensive range of medications and healthcare materials to military treatment programs and medical facilities worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.8k | 4/9/24 |